Breaking News

MedImmune Restructures Vaccines Business

To close Mountain View and Santa Clara sites

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MedImmune, the global biologics arm of AstraZeneca, is restructuring its infectious disease and vaccines research, development and operations, resulting in the closure of its Mountain View, CA and Santa Clara, CA sites, and the consolidation of its infectious disease and vaccines research and development activities to other sites. The changes will be implemented in 2014. MedImmune’s Hayward, CA site will remain open with additional capabilities invested there. The company estimates that approx...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters